Anti-Human Fc gamma RIIIA/CD16a0 Reference Antibody (MAT 302, RUO) (HF985036)

Datasheet Share product Copy info

Price(USD): $

Spec:

100ug
1mg

Number:

Overview
Images
References
Datasheet

Overview

Catalog No.	HF985036
Description	Anti-Human CD160 (MAT 302) (HF985036) is a research-grade recombinant antibody targeting CD160. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivity	Human
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species	Human
Isotype	IgG
Clone ID	MAT 302
Expression system	Mammalian Cells
Clonality	Monoclonal
Target	Natural killer cell receptor BY55, CD160 antigen, CD160, BY55
Endotoxin level	Please contact the lab for this information.
Purity	>95% purity as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	O95971
Form	Liquid
Storage buffer	0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names	MAT-302, MAT302, MAT302
Background	CD160 antigen is a ~19 kDa protein. Receptor on immune cells capable to deliver stimulatory or inhibitory signals that regulate cell activation and differentiation. Exists as a GPI-anchored and as a transmembrane form, each likely initiating distinct signaling pathways via phosphoinositol 3-kinase in activated NK cells and via LCK and CD247/CD3 zeta chain in activated T cells. Receptor for both classical and non-classical MHC class I molecules. In the context of acute viral infection, recognizes HLA-C and triggers NK cell cytotoxic activity, likely playing a role in anti-viral innate immune response. On CD8+ T cells, binds HLA-A2-B2M in complex with a viral peptide and provides a costimulatory signal to activated/memory T cells. 1. Nikolova, M. et al. (2002) International immunology 14, 445-51. PMID: 11978774 2. Rabot, M. et al. (2007) International immunology 19, 401-9. PMID: 17307798 3. Giustiniani, J. et al. (2009) Journal of immunology (Baltimore, Md. : 1950) 182, 63-71. PMID: 19109136 4. Le Bouteiller, P. et al. (2002) Proceedings of the National Academy of Sciences of the United States of America 99, 16963-8. PMID: 12486241 5. Agrawal, S. et al. (1999) Journal of immunology (Baltimore, Md. : 1950) 162, 1223-6. PMID: 9973372 6. Viganò, S. et al. (2014) PLoS pathogens 10, e1004380. PMID: 25255144 7. Fons, P. et al. (2006) Blood 108, 2608-15. PMID: 16809620 8. Cai, G. et al. (2008) Nature immunology 9, 176-85. PMID: 18193050
Note	For research use only. Not suitable for clinical or therapeutic use.